Related references
Note: Only part of the references are listed.ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice
Lisa A. Cassis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Interferon-γ and the Interferon-Inducible Chemokine CXCL10 Protect Against Aneurysm Formation and Rupture
Victoria L. King et al.
CIRCULATION (2009)
The TGF-beta paradox in human cancer: an update
Maozhen Tian et al.
FUTURE ONCOLOGY (2009)
Absence of TGFβ Signaling in Embryonic Vascular Smooth Muscle Leads to Reduced Lysyl Oxidase Expression, Impaired Elastogenesis, and Aneurysm
Bibha Choudhary et al.
GENESIS (2009)
Involvement of Vascular Angiotensin II-Forming Enzymes in the Progression of Aortic Abdominal Aneurysms in Angiotensin II-Infused ApoE-Deficient Mice
Nao Inoue et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Transforming Growth Factor-β Promotes Recruitment of Bone Marrow Cells and Bone Marrow-derived Mesenchymal Stem Cells through Stimulation of MCP-1 Production in Vascular Smooth Muscle Cells
Fan Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway
Delphine Gomez et al.
JOURNAL OF PATHOLOGY (2009)
The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-β, increases podocyte motility and albumin permeability
Eun Young Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice
Tracy Henriques et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The role of endothelial-to-mesenchymal transition in cancer progression
S. Potenta et al.
BRITISH JOURNAL OF CANCER (2008)
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome
Benjamin S. Brooke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Pierre-Jean Wipff et al.
JOURNAL OF CELL BIOLOGY (2007)
Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
Ronald V. Lacro et al.
AMERICAN HEART JOURNAL (2007)
Monocyte chemoattractant protein-1 production by intestinal myofibroblasts in response to staphylococcal enterotoxin A: Relevance to staphylococcal enterotoxigenic disease
Irina V. Pinchuk et al.
JOURNAL OF IMMUNOLOGY (2007)
Marfan syndrome: from molecular pathogenesis to clinical treatment
Francesco Ramirez et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice
Katsuhiro Hanada et al.
CIRCULATION RESEARCH (2007)
Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states
Ronald D. Cohn et al.
NATURE MEDICINE (2007)
Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms
Lisa A. Cassis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Aneurysm syndromes caused by mutations in the TGF-β receptor
Bart L. Loeys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome
PJ Coucke et al.
NATURE GENETICS (2006)
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
BL Loeys et al.
NATURE GENETICS (2005)
Heterozygous TGFBR2 mutations in Marfan syndrome
T Mizuguchi et al.
NATURE GENETICS (2004)
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice
M Ishibashi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways
JI Park et al.
ONCOGENE (2003)
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
ER Neptune et al.
NATURE GENETICS (2003)
Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa
B Loeys et al.
HUMAN MOLECULAR GENETICS (2002)
Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo
H Yanagisawa et al.
NATURE (2002)
Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis
A Daugherty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
